We are monitoring the impact of COVID-19 on Europe HIV Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2054
Share on
Share on

Europe HIV Diagnostics Market Research Report - Segmented By Product Type, End User & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 2054
Pages: 130

Europe Hiv Diagnostics Market Size & Growth (2021 to 2026):

The Gene Expression Analysis Market size in Europe is forecasted to grow at a CAGR of 9.1% during the forecast period 2021 to 2026. This market was worth USD 1.28 Billion in 2021 and is expected to worth USD 1.97 Billion by 2026.

The key driving factor heavily impacting the European HIV diagnostics market is the rising prevalence of HIV/Aids in the region. According to The Joint United Nations Programme (UNAIDS), approximately 40 million people had HIV/AIDS across the globe in 2018. Also reported that around 1.7 million were newly infected with the virus. Additionally, the growing number of blood transfusions and blood donations are expected to drive the market in the upcoming years.

To tackle the acute disease and its complications, the Local government takes initiatives to help healthcare infrastructure and awareness about the condition. The U.K had an expenditure of 12.8% of GDP in 2020, rising from 10.2% in 2019. The government is also makings strict rules to decrease the number of infections caused due to improper blood transfusions and blood donations leading to HIV. In addition, the government is focused on creating awareness about the preventive methods for HIV disease. In 2018, approximately USD 20,000 million funds were available for AIDS prevention and treatment in the U.K. In addition, many NGOs and healthcare facilities provide free AIDS preventive products to reduce the spread of the disease in European nations.

Technological advancements have made evolution for quick and reliable HIV diagnostics tests. The European HIV diagnostic market is driven by the availability of point-of-care instruments and test kits. These kits can be used in the home setting as well. There are a large number of companies working towards the development of cheaper and accessible HIV diagnostic kits. Rising fund for research and development sector to develop novel drugs to treat AIDS. 1.2 million deaths were owing to HIV-related complications in 2018. According to the CDC, more than 1.5 million people in the U.K. were infected with HIV where almost 19% of them were undiagnosed.

Recent advancements in point of care testing have resulted in developing many new kits such as antiretroviral therapy, cluster differentiation (CD4) tests, rapid diagnostic tests (RDTs), viral load tests, and HIV early-infant diagnosis tests. However, preventive tests in immigrants and healthcare professionals will also drive the market growth rate in the forecasted period.

The social stigma and embarrassment associated with AIDS and HIV have a huge retarding impact on the market and lack of knowledge about the preventive measures needed for AIDS infection. Moreover, a lack of development and funds is required for research in many developing economies hampering the European HIV diagnostics market.

This research report on the Europe HIV Diagnostics Market has been segmented and sub-segmented into the following categories:

By Product:

  • Consumables
  • Instruments
  • Software
  • Services                

By Type:

  • Antibody Tests
  • Viral Identification Tests
  • CD4 Testing
  • Viral Load testing
  • Early Infant Diagnostics              

By End User:

  • Diagnostic Laboratories
  • Hospitals
  • Blood Banks
  • Home Care Settings
  • Other End Users             

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the Europe is one of the highest regions suffering due to HIV/AIDS. However, the European region is expected to gather good opportunities due to developing healthcare facilities, a high rate of blood transfusions, the growing rate of IV drug addicts, a large population, and growing innovations in the medical field.

France and Germany are estimated to grow at a high CAGR rate during the projected period. This market growth is due to the increasing focus on developing test kits and the presence of research laboratories and companies in the region. In 2019, nearly 165,000 people were diagnosed with HIV in Europe. According to a renowned Institute report, approximately 85,000 people were infected with HIV in Germany in 2017. According to AVERT, more than 2.5 million people are living with HIV/AIDS in Europe, and nearly 80,000 people die due to AIDS infection.

Other regions in Europe are also expected to have lucrative CAGR due to the increased prevalence of HIV and the growing need for diagnostic procedures, boosting the European HIV diagnostics market growth. Furthermore, due to their various factors, the demand is gathering international market players for the manufacture and distribution of technologically advanced rapid testing kits and instruments. All these factors will aid the growth of the HIV diagnostics market in the coming years.

KEY MARKET PLAYERS

Key players operating in the Europe HIV diagnostics Market profiled in this report are Abbott Healthcare, Brsitol-Myers Squibb, Alere Inc., Abbvie Inc., Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, BD Biosciences, Beckman Coulter, Partec, Sysmex, VIIV Healthcare, Apogee Flow Systems, Mylan inc., PointCare Technologies Inc., Zyomyx Inc., Roche Diagnostics, Qiagen, Siemens Healthcare, and bioMerieux.

1.Introduction  

                1.1 Market Definition  

                1.2 Study Deliverables

                1.3 Base Currency, Base Year and Forecast Periods        

                1.4 General Study Assumptions  

2. Research Methodology                         

                2.1 Introduction             

                2.2 Research Phases    

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design       

                2.4 Study Timeline        

3. Overview                     

                3.1 Executive Summary  

                3.2 Key Inferences       

                3.3 Epidemology            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers        

                4.2 Market Restraints  

                4.3 Key Challenges       

                4.4 Current Opportunities in the Market            

5. Market Segmentation                            

                5.1 Product      

                                5.1.1 Introduction                                                           

                                5.1.2 Consumables                                                         

                                                5.1.2.1 Assays and Kits &Reagents                                           

                                                5.1.2.2 Other Consumables                                        

                                5.1.3 Instruments                                                           

                                5.1.4 Software & Services                                                            

                                5.1.5  Y-o-Y Growth Analysis, By Product                                                              

                                5.1.6  Market Attractiveness Analysis, By Product                                                            

                                5.1.7  Market Share Analysis, By Product                                                              

                5.2 Type            

                                5.2.1 Introduction                                                           

                                5.2.2 Antibody Tests                                                      

                                                5.2.2.1 HIV Screening Tests                                         

  5.2.2.1.1 Elisa                    

  5.2.2.1.2 Rapid Tests                      

  5.2.2.1.3 Home Access Dried Blood Spots                             

                                                5.2.2.2 HIV-1 Antibody Confirmatory Tests                                          

  5.2.2.2.1 Western Blot Tests                       

  5.2.2.2.2  Indirect Immunofluorescence Assays (IFA)                      

  5.2.2.2.3 Line Immunoassays                     

  5.2.2.2.4 Radio-Immunoprecipitation Assays                      

                                                5.2.2.3  HIV-2 & Group O Diagnostic Tests                                            

  5.2.2.3.1 Blood Antibody Tests                  

  5.2.2.3.2 DBS Tests                         

  5.2.2.3.3 Line ImmunoAssay (HIV2)                         

                                5.2.3 Viral Identification Tests                                                    

                                                5.2.3.1 p24 Antigen Test                                               

                                                5.2.3.2 Qualitative PCR Tests                                      

                                                5.2.3.3 Viral Culture                                        

                                5.2.4 CD4 Testing                                                             

                                5.2.5 Viral Load testing                                                  

                                5.2.6 Early Infant Diagnostics                                                      

                                5.2.7 Y-o-Y Growth Analysis, By Type                                                     

                                5.2.8 Market Attractiveness Analysis, By Type                                                   

                                5.2.9 Market Share Analysis, By Type                                                     

                5.3 End User    

                                5.3.1 Introduction                                                           

                                5.3.2 Diagnostic Laboratories                                                     

                                5.3.3 Hospitals                                                  

                                5.3.4 Blood Banks                                                            

                                5.3.5 Home Care Settings                                                            

                                5.3.6 Other End Users                                                   

                                5.3.7 Y-o-Y Growth Analysis, By End User                                                             

                                5.3.8  Market Attractiveness Analysis, By End User                                                          

                                5.3.9  Market Share Analysis, By End User                                                            

6. Geographical Analysis                            

                6.1 Introduction             

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Product                                           

                                                6.1.3.3 By Type                                 

                                                6.1.3.4 By End User                                        

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Product                                           

                                                6.1.4.3 By Type                                 

                                                6.1.4.4 By End User                                        

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Product                                           

                                                6.1.5.3 By Type                                 

                                                6.1.5.4 By End User                                        

                6.2 U.K   

                6.3 Spain           

                6.4 Germany   

                6.5 Italy             

                6.6 France        

7.Strategic Analysis                      

                7.1 PESTLE analysis       

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis            

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis         

  8.1 Siemens Healthineers (A Division of Siemens AG)                                     

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

  8.2 Roche Diagnostics (Division of Hoffman La Roche Ltd.)                                            

  8.3 Abbott Laboratories                                               

  8.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)                                  

  8.5 Thermo-Fisher Scientific Inc.                                               

  8.6 Merck KGaA                                               

   8.7 Becton, Dickinson & Company                                           

   8.8 Hologic Inc.                                 

    8.9 Alere Inc.                                     

     8.10 Bio-Rad Laboratories                                            

9. Competitive Landscape                                                            

       9.1 Market share analysis                                            

        9.2 Merger and Acquisition Analysis                                       

        9.3 Agreements, collaborations and Joint Ventures                                         

       9.4 New Product Launches                                         

  10. Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                               

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Europe HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  2. Europe Consumables Market By Region, From 2021 to 2026 ( USD Billion )
  3. Europe Instruments Market By Region, From 2021 to 2026 ( USD Billion )
  4. Europe Software & Services Market By Region, From 2021 to 2026 ( USD Billion )
  5. Europe HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  6. Europe Antibody Tests Market By Region, From 2021 to 2026 ( USD Billion )
  7. Europe Viral Identification tests Market By Region, From 2021 to 2026 ( USD Billion )
  8. Europe CD4 Testing Market By Region, From 2021 to 2026 ( USD Billion )
  9. Europe Viral Load Testing Market By Region, From 2021 to 2026 ( USD Billion )
  10. Europe Early Infant Diagnosticss Market By Region, From 2021 to 2026 ( USD Billion )
  11. Europe HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )
  12. Europe Diagnostic Labortaries Market By Region, From 2021 to 2026 ( USD Billion )
  13. Europe Hospitals Market By Region, From 2021 to 2026 ( USD Billion )
  14. Europe Blood Banks Market By Region, From 2021 to 2026 ( USD Billion )
  15. Europe Home Care Settings Market By Region, From 2021 to 2026 ( USD Billion )
  16. Europe Other End Users Market By Region, From 2021 to 2026 ( USD Billion )
  17. U.K. HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  18. U.K. HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  19. U.K. HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )
  20. Germany HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  21. Germany HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  22. Germany HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )
  23. France HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  24. France HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  25. France HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )
  26. Italy HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  27. Italy HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  28. Italy HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )
  29. Spain HIV Diagnostics Market By Product, From 2021 to 2026 ( USD Billion )
  30. Spain HIV Diagnostics Market By Type, From 2021 to 2026 ( USD Billion )
  31. Spain HIV Diagnostics Market By End-User, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample